Update in herpetic retinitis;Herpès et lésions rétiniènes: Quoi de neuf?

Pathologie Biologie

Volumn 50, Issue 7, 2002, Pages 452-459

  Fardeau, C ^a   Slimane, H ^a   Lehoang, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiherpetic drugs; Cytomegalovirus; Herpes simplex virus; Herpetic retinitis; Varicella zoster virus

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTICOAGULANT AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTITHROMBOCYTIC AGENT; CIDOFOVIR; CORTICOSTEROID; FAMCICLOVIR; FOSCARNET SODIUM; GANCICLOVIR; NUCLEOSIDE DERIVATIVE; PREDNISONE; PYROPHOSPHORIC ACID DERIVATIVE; VALACICLOVIR;

ANTICOAGULANT THERAPY; ARTICLE; CHEMOPROPHYLAXIS; CYTOMEGALOVIRUS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MECHANISM; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEPHROTOXICITY; NEUROTOXICITY; OPTIC NERVE DISEASE; RETINA DETACHMENT; RETINA NECROSIS; RETINITIS; STEROID THERAPY; UVEITIS; VARICELLA ZOSTER VIRUS; VIRAL CONTAMINATION; VIRUS RESISTANCE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, VIRAL; HERPES SIMPLEX; HERPES ZOSTER OPHTHALMICUS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; OPPORTUNISTIC INFECTIONS; OPTIC NEURITIS; RETINAL DETACHMENT; RETINAL NECROSIS SYNDROME, ACUTE; RETINITIS;

EID: 0036694255     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00334-6     Document Type: Article

References (38)

1. Uruyama A, Yamada N, Sasaki T, et al. Unilateral acute uveitis with peri-arteritis and detachment. Jpn J Clin Ophthalmol 1971;25: 607-19.
2. Porter R. Acute necrotizing retinitis in a patient receiving immunosupressive therapy. Br J Ophthalmol 1972;56:555.
3. Freeman W, Thomas E, Narsing A, Pepose J. Demonstration of herpes group virus in acute retinal nacrosis syndrome. Am J Ophthalmol 1986;102:701-9.
4. Culbertson WW. Infections of the retina in AIDS. International ophthalmology clinics 1989;29:108-17.
5. Nishi M, Hanashiro R, Mori S, Masuda K, Mochizuki M, Hondo R. Polymerase chain reaction for the detection of the varicella virus in ocular samples from patients with acute retinal necrosisμ. Am J Ophthalmol 1992;114(5):603-5.
6. Ganatra JB, et al. Am J Ophthalmol 2000;129:166-72.
7. Margolis TP, Lowder CY, Holland GN, et al. Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1991;112:119-31.
8. Batisse D, Eliaszewicz M, Zazoun L, Baudrimont M, Pialoux G, Dupont B. Acute retinal necrosis in the course of AIDS: study of 26 cases. AIDS 1996;10(1):55-60.
9. Zamora RL, Priore del LV, Storch GA, Gelb LD, Sharp J. Multiple recurrent branch retinal artery occlusions associated with varicella zoster virus. Retina 1996;16(5):399-404.
10. Moorthy RS, Weinberg DV, Teich SA, Berger BB, Minturn JT, Kumar S, Rao NA, Fowell SM, Loose IA, Jampol LM. Managment of varicella zoster virus retinitis in AIDS. NBr J Ophthalmol 1997;81(3):189-94.
11. Forster J, Dugel PU, Frangieh GT, et al. Rapidly progressive outer necrosis in the acquired immunodeficiency syndrome. Am. J. Ophthalmol. 1990;110:341-8.
12. Bodaghi B. Rapport de la Société française d'ophtalmologie. Paris: Masson; 2000.
13. Boer De JH, Verhagen C, Bruinenberg M, Rothova A, Jong de PT, Baarsma GS, Lelij Van der A, Ooyman FM, Bollemeijer JS, Derhaag PJ, Kijlstra A. Serologic and polymerase chain reaction analysis in intraocular fluids in the diagnosis of infectious uveitis. Am. J. Ophthalmol. 1996;121(6):650-8.
14. Risk for retinitis in patients with AIDS can be assessed by quantification of threshold levels of cytomegalovirus DNA burden in blood. J Infect Dis 1997;176:1146-55.
15. Holland GN, Buhles WC, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV retinopathy study group. Arch Ophthalmol 1989;107:1759-66.
16. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the foscarnet-gancyclovir cytomegalovirus retinitis trial. The studies of ocular complications of AIDS (SOCA) research group in collaboration with the AIDS clinical trials group (ACTG). Am J Ophthalmol 1997;124:61-70.
17. Rao NA, Zhan J, Hishimoto S. Role of retinal vascular endothelial cells in development of CMV retinitis. Trans Plan AM Ophthalmol Sos 1998;96:11-26.
18. Reux I, Fillet AM, Agut H, Katlama C, Hauw JJ, Lehoang P. In situ detection of human herpes virus 6 in retinitis associated with acquired immunodeficiency syndrome. Am J Ophthalmol 1992;114: 375-7.
19. Cassoux N. "Ocular manifestations of AIDS". Ocular Inflammation Basic and Clinical Concepts. D. BenEzra Ed, Martinn Dunitz Ltd; 1999.
20. Cassoux N, Lumbroso L, Bodaghi B, et al. Cystoid macular oedema et cytomegalovirus retinitis in patients with HIV disease traited with highly active antiretroviral therapy. Br. J. Ophthal. 1999;83:47-9.
21. Young S, Bom S, Lightman S. Lancet 2000;355:984.
22. Perry CM, Faulds D. Valacyclovir. Review of Its antiviral activity, pharmacokinetics properties and therapeutic efficacy in herpes virus infections. Drugs 1996;52:754-72.
23. Bacon TP, Schinazi RF. An Overview of the further evaluation of penciclovir against herpes simplex virus and varicella zoster virus in cell culture highlighting contrasts with Acyclovir. Antiviral Chem. Chemother. 1993;4(suppl.):25-6.
24. Figueroa MS, Garabito I, Gutierrez C, Fortun J. Famciclovir for the treatment of acute retinal necrosis syndrome. Am J Ophthalmol 1997;123:255-7.
25. Tambasco FP, et al. Oral Acyclovir after penetrating keratoplasty for herpes simples keratitis. Arch. Ophthal. 1999;117:445-9.
26. Colin J, Robinet A, Malet F. Traitement préventif des kératites herpétiques par l' Acyclovir en comprimé. J Fr Ophtalmol. 1993;16: 6-9.
27. The herpetic eyes diseases study group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998;339:300-6.
28. Cunningham ET, Margolis TP. Ocular manifestations of HIV infection. N Eng J Med 1998;339:236-44.
29. Fardeau C, Langlois M, Mathys B, Rafales P, Nugier F, Godard V, Aymard M, Denis J, Denis C. Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis. Curr Eye Res 1991;10(Suppl):151-8.
30. Fillet, Jacobson MA, Berger TG, Fikrig S, Becherer P, Moohr JW, Stanat SC, Biron KK. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1990;112: 187-91.
31. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. Studies of ocular complications of AIDS research group, in collaboration with the AIDS clinical trials group. N Eng J Med 1992;326:213-20.
32. Cochereau-Massin I, Lehoang P, Lautier-Frau M, Zazoun L, Marcel P, Robinet M, Matheron S, Katlama C, Gharakhanian S, Rozenbaum W, et al. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1991;98:1348-55.
33. Diaz-Llopis M, Espana E, Munoz G, Navea A, Chipont E, Cano J, Menezo JL, Romero FJ. High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. Br J Ophthalmol 1994;78:120-4.
34. Lalezari JP, Stagg RJ, Kupperman BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MDR, Drew WL, Jaffe HS. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized controlled trial. Ann Intern Med 1997; 126:257-63.
35. Akler ME, Jonhson DW, Burman WJ, Johnson SC. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology 1998;105:651-7.
36. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The oral ganciclovir European and Australian cooperative study group. AIDS 1995;9: 471-7.
37. Whitley RJ, Holland GN. Cytomegalovirus retinitis-evolving therapies in a new era. N. Engl. J. Med. 1999;340:1109-10.
38. Vrabec TR, Baldassano VF, Whitcup SM. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 1998;105:1259-64.